'Jlane3965' I just saw this too / fabulous news, aphriaLATAM - Preliminary results of the pediatric refractory #epilepsy clinical study led by @HospGarrahan in #Argentina report a medium decrease of 66% in the frequency of seizures. Find the report published by @SeizureJournal. https://bit.ly/2zHsIBC. $APHA #research #Neurology
As we continue to hunt for top opportunities across a variety of markets positioned to deliver potential outsized gains for interested investors this fall, we turn our attention to the cannabis space.
This may be one of the more interesting opportunities staring at market participants, ready to define the coming three months into the US election on November 3. In 2016, the cannabis space exploded in an orgy of speculative fervor, with stocks in the group moving up in some cases thousands of percentage points in value. While much of that was later reversed, the thematic energy around the progressive legalization agenda was a massive catalyst for stocks with related operations.
And so it may be once again this year. However, this time around, the group may be much better positioned for more sustainable gains in value given the drop in number of producers and the transition of productive assets from weak to strong balance sheets – two common fruits of contraction cycles.
With that in mind, we take a look here at a handful of companies that have executed at the top of the space on different dimensions in their own respective niches, including: Aphria Inc (NASDAQ:APHA), Curaleaf Holdings Inc (OTCMKTS:CURLF), Sugarmade Inc (OTCMKTS:SGMD), GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH).
Aphria Inc (NASDAQ:APHA) recently received a notable upgrade from Stifel analyst W. Andrew Carter, and then picked up more distribution partnerships to continue to show off the characteristics of a long-term group leader.
The company recently announced it has entered into a Strategic Supply Agreement with Canndoc Ltd., a subsidiary of InterCure Ltd. (TASE: INCR) (TASE: INCR.TA), one of Israel’s largest and most established medical cannabis producers.
According to the release, under the terms of the Agreement, Aphria will supply Canndoc with dried bulk flower over a two-year period, with the option to extend for two additional terms of two years each, and an option for an additional year after that if the parties agree to terms. During the first two-year term and each additional term, if applicable, the Company will provide Canndoc with 3,000 kgs. of bulk dried flower, which will be processed into finished product, co-branded under the Aphria and Canndoc brand names, and sold exclusively within the Israeli market.
Aphria Inc (NASDAQ:APHA) is a leading global cannabis company driven by “an unrelenting commitment to our people, product quality and innovation.”
Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company touts itself as one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis.
The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 5% in that timeframe.
Aphria Inc (NASDAQ:APHA) generated sales of $152.2M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 5.8% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($497.2M against $170.4M).
The Alcohol and Gaming Commission of Ontario (AGCO) continues to work with the Government of Ontario on opportunities to increase the number of cannabis Retail Store Authorizations (RSAs) that can be issued each month.
Last December, as part of the steps taken to move to an open market for cannabis retail stores, the government announced that starting April 2020, the AGCO would begin by issuing up to 20 RSAs per month. In all, the AGCO has issued 164 RSAs to date and 150 stores are currently open.
At the government’s direction, the AGCO is now moving to double the pace of store authorizations this fall. The AGCO will soon contact all affected retail store applicants directly to advise them of any change to the timing of the issuance of their store authorizations.
News 
Market Data 
Discover 
